Lisanti Capital Growth’s NEVRO CORP. NVRO Stock Holding History

Lisanti Capital Growth’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-54,302	Closed	-$9.4M	–	172
2020 Q4	$9.4M	Sell	54,302 -13,385	-20%	-$2.17M	1.3%	25
2020 Q3	$9.43M	Buy	67,687 +10,178	+18%	+$1.36M	1.75%	12
2020 Q2	$6.87M	Buy	57,509 +8,055	+16%	+$955K	1.4%	17
2020 Q1	$4.94M	Buy	49,454 +18,480	+60%	+$2.22M	1.63%	17
2019 Q4	$3.64M	Buy	30,974 +16,519	+114%	+$1.64M	0.97%	45
2019 Q3	$1.24M	Buy	+14,455	New	+$1.09M	0.41%	76
2019 Q2	–	Sell	-13,415	Closed	-$839K	–	132
2019 Q1	$839K	Buy	+13,415	New	+$631K	0.3%	100
2018 Q2	–	Sell	-30,370	Closed	-$2.63M	–	158
2018 Q1	$2.63M	Buy	+30,370	New	+$2.45M	1.27%	26
2017 Q4	–	Sell	-11,255	Closed	-$1.02M	–	133
2017 Q3	$1.02M	Buy	+11,255	New	+$964K	0.64%	69
2017 Q2	–	Sell	-5,965	Closed	-$559K	–	126
2017 Q1	$559K	Buy	+5,965	New	+$540K	0.8%	66
2016 Q4	–	Sell	-8,570	Closed	-$895K	–	108
2016 Q3	$895K	Sell	8,570 -1,390	-14%	-$126K	1.13%	40
2016 Q2	$735K	Buy	+9,960	New	+$676K	1.11%	40
2016 Q1	–	Sell	-16,618	Closed	-$1.12M	–	111
2015 Q4	$1.12M	Buy	+16,618	New	+$890K	1.18%	37

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lisanti Capital Growth's NVRO Position: Q1 2021 in Review

Lisanti Capital Growth sold out of NEVRO CORP. (NVRO) in Q1 2021, closing a stake of 54,302 shares — an estimated $9.4M sold.

Lisanti Capital Growth first reported a position in NVRO in Q4 2015 and held it in 13 quarters. The position peaked at $9.43M in Q3 2020. 204 funds tracked by Wall St. Rank hold NVRO as of Q1 2021.

Lisanti Capital Growth reported no remaining NEVRO CORP. position as of Q1 2021 after selling out during the quarter.
Lisanti Capital Growth sold 54,302 NEVRO CORP. shares in Q1 2021, an estimated $9.4M.
Lisanti Capital Growth first reported a position in NEVRO CORP. in Q4 2015 and held it in 13 quarters.
Lisanti Capital Growth's NEVRO CORP. position peaked at $9.43M in Q3 2020.
204 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2021.

Based on Lisanti Capital Growth's 13F filing for Q1 2021, filed 12 May 2021.